Healthcare Industry News: bone cement
News Release - February 24, 2021
G21(R) announces the FDA Clearance of SpaceFlex Shoulder(TM) : The unique complete line of Custom Modular Spacers available worldwideSAN POSSIDONIO, Italy, Feb. 24, 2021 -- (Healthcare Sales & Marketing Network) -- G21® S.r.l., a bone cement manufacturer company, is pleased to announce the clearance of SpaceFlex Shoulder™ as a completion of its existing Spaceflex line: Hip and Knee.
"The achievement of this result for G21® S.r.l. means being able to offer a dedicated treatment of each infected joint," says Filippo Foroni, Executive Vice President of G21® S.r.l. "Since we set up the company in 2009, we are committed to provide our patients with better health conditions. The addition of SpaceFlex Shoulder™ to our product portfolio represents a user-friendly solution for complex issues."
About G21® S.r.l.
G21® S.r.l. offers a range of products for both orthopedics and minimally invasive spine surgery. G21® S.r.l. provides bone cement for orthopedics with different levels of viscosity for the making of temporary prothesis for the treatment of infections and septic revisions. G21® S.r.l. supplies bone cement for vertebral consolidation for the performing of minimally invasive spine surgeries such as vertebroplasty and kyphoplasty procedures.
SpaceFlex Shoulder™ is officially available on the US Market.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.